Ken Takeshima

682 total citations
34 papers, 476 citations indexed

About

Ken Takeshima is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Rheumatology. According to data from OpenAlex, Ken Takeshima has authored 34 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Epidemiology and 10 papers in Rheumatology. Recurrent topics in Ken Takeshima's work include Neuroendocrine Tumor Research Advances (10 papers), IgG4-Related and Inflammatory Diseases (9 papers) and Pituitary Gland Disorders and Treatments (6 papers). Ken Takeshima is often cited by papers focused on Neuroendocrine Tumor Research Advances (10 papers), IgG4-Related and Inflammatory Diseases (9 papers) and Pituitary Gland Disorders and Treatments (6 papers). Ken Takeshima collaborates with scholars based in Japan, United States and Sri Lanka. Ken Takeshima's co-authors include Takashi Akamizu, Hiroyuki Ariyasu, Hidefumi Inaba, Shinsuke Uraki, Shuhei Morita, Hiroshi Iwakura, Yasushi Furukawa, Masahiro Nishi, Hiroto Furuta and Asako Doi and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Ken Takeshima

30 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Takeshima Japan 14 189 168 145 113 86 34 476
Angeliki M. Stamatouli United States 5 118 0.6× 433 2.6× 98 0.7× 21 0.2× 78 0.9× 9 631
Nabeel Al-Brahim Kuwait 13 47 0.2× 132 0.8× 156 1.1× 47 0.4× 150 1.7× 28 447
Claire Coire Canada 13 91 0.5× 72 0.4× 216 1.5× 48 0.4× 140 1.6× 18 415
Toshiaki Sano Japan 12 92 0.5× 54 0.3× 153 1.1× 94 0.8× 127 1.5× 16 518
David López United States 9 271 1.4× 51 0.3× 31 0.2× 72 0.6× 135 1.6× 19 532
Lenka Krsková Czechia 12 54 0.3× 128 0.8× 95 0.7× 29 0.3× 58 0.7× 55 455
Edward J. Fudman United States 9 193 1.0× 50 0.3× 56 0.4× 274 2.4× 37 0.4× 10 598
Nadia Cremonini Italy 12 159 0.8× 101 0.6× 427 2.9× 25 0.2× 174 2.0× 20 546
Maria Acevedo-Calado Spain 12 79 0.4× 34 0.2× 109 0.8× 59 0.5× 187 2.2× 18 481
Françoise Parmentier France 10 38 0.2× 103 0.6× 120 0.8× 24 0.2× 122 1.4× 16 482

Countries citing papers authored by Ken Takeshima

Since Specialization
Citations

This map shows the geographic impact of Ken Takeshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Takeshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Takeshima more than expected).

Fields of papers citing papers by Ken Takeshima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Takeshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Takeshima. The network helps show where Ken Takeshima may publish in the future.

Co-authorship network of co-authors of Ken Takeshima

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Takeshima. A scholar is included among the top collaborators of Ken Takeshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Takeshima. Ken Takeshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakao, Tomomi, Ken Takeshima, Shuhei Morita, et al.. (2025). Tumor-Induced Osteomalacia Localized by Systemic Venous Sampling and 68Ga-DOTATOC Positron Emission Tomography. JCEM Case Reports. 3(2). luaf012–luaf012.
2.
Morita, Shuhei, et al.. (2025). Severe obesity with hypo-leptinemia. Endocrine Journal. 72(7). 801–811.
3.
Furukawa, Yasushi, Takashi Akamizu, Asako Doi, et al.. (2024). Generation of a mouse model of thyroid storm and preliminary investigation of the therapeutic effects of ghrelin. BMC Endocrine Disorders. 24(1). 150–150.
4.
Nakao, Tomomi, Ken Takeshima, Yasushi Furukawa, et al.. (2024). Impact of angiotensin receptor neprilysin inhibitor on serum C-peptide levels in patients with type 2 diabetes. Diabetology International. 16(1). 194–198. 1 indexed citations
5.
Iwakura, Hiroshi, Hidefumi Inaba, Asako Doi, et al.. (2023). Thyroid function, glycemic control, and diabetic nephropathy in patients with type 2 diabetes over 24 months: prospective observational study. BMC Endocrine Disorders. 23(1). 146–146. 6 indexed citations
6.
Morita, Shuhei, Shinsuke Uraki, Ken Takeshima, et al.. (2022). Isolated ACTH deficiency following immunization with the BNT162b2 SARS-CoV-2 vaccine: a case report. BMC Endocrine Disorders. 22(1). 185–185. 27 indexed citations
7.
Morita, Shuhei, Shinsuke Uraki, Ken Takeshima, et al.. (2022). Hypopituitarism and cranial nerve involvement mimicking Tolosa-Hunt syndrome as the initially presenting feature of diffuse large B-cell lymphoma: a case report. BMC Endocrine Disorders. 22(1). 65–65. 2 indexed citations
8.
Takeshima, Ken, et al.. (2021). Deterioration of pituitary function without relapse after steroid therapy for IgG4-related hypophysitis. Endocrinology Diabetes and Metabolism Case Reports. 2021. 4 indexed citations
9.
Uraki, Shinsuke, Hiroyuki Ariyasu, Asako Doi, et al.. (2020). MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes. International Journal of Molecular Sciences. 21(8). 2831–2831. 28 indexed citations
10.
Inaba, Hidefumi, Hiroyuki Ariyasu, Hiroshi Iwakura, et al.. (2020). Autoimmune polyglandular syndrome type 2 and autoimmune hepatitis with thymoma-associated myasthenia gravis: case report. BMC Endocrine Disorders. 20(1). 6 indexed citations
11.
Inaba, Hidefumi, Hiroyuki Ariyasu, Hiroshi Iwakura, et al.. (2020). Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune‐checkpoint inhibitors. Cancer Science. 111(5). 1468–1477. 109 indexed citations
12.
Takeshima, Ken, Masahiro Nishi, Hiroyuki Ariyasu, et al.. (2020). The influence of thyroid autoimmunity on pregnancy outcome in infertile women: a prospective study. Endocrine Journal. 67(8). 859–868. 13 indexed citations
13.
Morita, Shuhei, Ken Takeshima, Hiroyuki Ariyasu, et al.. (2020). Expression of unfolded protein response markers in the pheochromocytoma with Waardenburg syndrome: a case report. BMC Endocrine Disorders. 20(1). 90–90. 4 indexed citations
14.
Nakao, Tomomi, Ken Takeshima, Hiroyuki Ariyasu, et al.. (2020). Thyroid storm with delayed hyperbilirubinemia and severe heart failure: indication and contraindication of plasma exchange. Endocrinology Diabetes and Metabolism Case Reports. 2020. 2 indexed citations
15.
Inaba, Hidefumi, Hiroyuki Ariyasu, Hiroshi Iwakura, et al.. (2019). Comparative analysis of human leucocyte antigen between idiopathic and anti‐PD‐1 antibody induced isolated adrenocorticotropic hormone deficiency: A pilot study. Clinical Endocrinology. 91(6). 786–792. 23 indexed citations
16.
Inaba, Hidefumi, Hiroyuki Ariyasu, Ken Takeshima, Hiroshi Iwakura, & Takashi Akamizu. (2019). Comprehensive research on thyroid diseases associated with autoimmunity: autoimmune thyroid diseases, thyroid diseases during immune-checkpoint inhibitors therapy, and immunoglobulin-G4-associated thyroid diseases. Endocrine Journal. 66(10). 843–852. 16 indexed citations
17.
Ariyasu, Hiroyuki, Shinsuke Uraki, Ken Takeshima, et al.. (2018). Imbalanced Expression of IGF2 and PCSK4 Is Associated With Overproduction of Big IGF2 in SFT With NICTH: A Pilot Study. The Journal of Clinical Endocrinology & Metabolism. 103(7). 2728–2734. 10 indexed citations
18.
Takeshima, Ken, Hiroyuki Ariyasu, Hiroshi Iwakura, et al.. (2018). Predominant Improvement of Alpha Cell Function after Steroid Therapy in a Patient with Autoimmune Pancreatitis: Case Report. Diabetes Therapy. 9(3). 1385–1395. 4 indexed citations
19.
Takeshima, Ken, Hidefumi Inaba, Yasushi Furukawa, et al.. (2013). Elevated Serum Immunoglobulin G4 Levels in Patients with Graves' Disease and Their Clinical Implications. Thyroid. 24(4). 736–743. 43 indexed citations
20.
Inaba, Hidefumi, Takahiro Hayakawa, Ken Takeshima, et al.. (2013). IgG4-related Ocular Adnexal Disease Mimicking Thyroid-associated Orbitopathy. Internal Medicine. 52(22). 2545–2551. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angeliki M. Stamatouli Breakdown of academic impact, for papers by Nabeel Al-Brahim Breakdown of academic impact, for papers by Claire Coire Breakdown of academic impact, for papers by Toshiaki Sano Breakdown of academic impact, for papers by David López Breakdown of academic impact, for papers by Lenka Krsková Breakdown of academic impact, for papers by Edward J. Fudman Breakdown of academic impact, for papers by Nadia Cremonini Breakdown of academic impact, for papers by Maria Acevedo-Calado Breakdown of academic impact, for papers by Françoise Parmentier
Rankless by CCL
2026